How many employees does Legend Biotech Corporation have?

Legend Biotech Corporation reported 2,900 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 10, 2026. That is up 11.5% from a year earlier.

What is Legend Biotech Corporation's revenue per employee?

Legend Biotech Corporation brought in $1.03B of revenue in fiscal Dec 2025, which is $355K per employee. That ranks 28 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Legend Biotech Corporation employees and revenue per employee

LEGN · Biotechnology · $3.46B market cap

Legend Biotech Corporation had 2,900 employees at the end of fiscal Dec 2025, up 11.5% from a year earlier. Revenue for the year was $1.03B, up 64.0% from a year earlier, or $355K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

2,900

+11.5% YoY

Revenue

$1.03B

+64.0% YoY

Revenue / employee

$355K

Peer median $602K

Rank in industry

28 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020

Hover a year for the numbers.

LEGN employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	2,900	$1.03B	$355K	+11.5%	+64.0%
Dec 2024	2,600	$627M	$241K	+44.4%	+120.0%
Dec 2023	1,800	$285M	$158K	+29.5%	+143.7%
Dec 2022	1,390	$117M	$84K	+29.8%	+70.0%
Dec 2021	1,071	$68.8M	$64K	+21.4%	-8.2%
Dec 2020	882	$75.0M	$85K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Legend Biotech Corporation against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
HALO Halozyme Therapeutics, Inc.	423	$1.40B	$3.30M	Efficient growth
BCRX BioCryst Pharmaceuticals, Inc.	435	$875M	$2.01M	Leaner
ARWR Arrowhead Pharmaceuticals, Inc.	711	$829M	$1.17M	Efficient growth
MDGL Madrigal Pharmaceuticals, Inc.	915	$958M	$1.05M	Efficient growth
AXSM Axsome Therapeutics, Inc.	925	$638M	$690K	Efficient growth
IONS Ionis Pharmaceuticals, Inc.	1,402	$944M	$673K	Efficient growth
TXG 10x Genomics, Inc.	1,178	$643M	$546K	Leaner
TECH Bio-Techne Corporation	3,000	$1.22B	$405K	Contracting
LEGN Legend Biotech Corporation	2,900	$1.03B	$355K	Efficient growth

Every Healthcare company

Questions about Legend Biotech Corporation

How many employees does Legend Biotech Corporation have?: Legend Biotech Corporation reported 2,900 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 10, 2026. That is up 11.5% from a year earlier.
What is Legend Biotech Corporation's revenue per employee?: Legend Biotech Corporation brought in $1.03B of revenue in fiscal Dec 2025, which is $355K per employee. That ranks 28 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare LEGN with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Legend Biotech Corporation's annual reports (Form 10-K), latest filed March 10, 2026. This is data, not a recommendation to buy or sell LEGN.